American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The TQCC of American Journal of Clinical Oncology-Cancer Clinical Trials is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody40
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer40
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer30
The Impact of COVID-19 on Patients With Cancer28
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer24
Breast and Cervical Cancer Screening Disparities in Transgender People21
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment20
Vaccination and Immune Checkpoint Inhibitors19
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States19
Social Determinants of Health in Oncology13
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma13
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases13
Proton Pump Inhibitors and Cancer Risk12
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma11
Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer11
Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma10
Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer10
Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States10
Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy10
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO)9
Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors9
Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy9
Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer9
Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC)9
Clinical Trials Before, During, and After COVID-19 Pandemic8
Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors8
Stereotactic Body Radiotherapy and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer8
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning8
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer8
The Early Impact of the COVID-19 Pandemic on Lung, Colorectal, and Breast Cancer Screening and Treatment at a Tertiary Cancer Center8
Management Strategies for Patients With Epithelioid Hemangioendothelioma8
Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia8
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies7
Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer7
Outcomes of Immune Checkpoint Inhibitor–related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections7
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma7
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer7
A Chitosan-Coated Chamomile Microparticles Formulation to Prevent Radiodermatitis in Breast7
Tumor Necrotic Debris and High Nuclear Grade7
Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer7
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer7
Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases7
Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens7
Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology6
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases6
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma6
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer6
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients6
Prior Treatment for Non–small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy6
Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique6
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy6
Regional Variation in Access to Oncologic Care and Racial Disparities Among Cervical Cancer Patients6
Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer6
Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy5
Journey to Diversity in a University Radiation Oncology Residency Program5
Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer5
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy5
Sepsis Hospitalizations With Versus Without Cancer5
Expansion of the LabBM Score5
Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database5
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy5
Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer5
Concurrent Nab-paclitaxel and Radiotherapy5
Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers5
Risk Factors for Recurrence and the Role of Radiotherapy in Low-grade Myofibroblastic Sarcoma5
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy5
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?5
Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer5
Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?4
Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy4
Celecoxib and Myrtol4
Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum4
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease4
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures4
Use of “Repurposed” Drugs in the Treatment of Epithelial Ovarian Cancer4
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 20154
Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma4
Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection4
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer4
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer4
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies4
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer4
Stereotactic Partial Breast Irradiation3
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei3
Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare3
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non−Small Cell Lung Cancer3
Synovial Sarcoma of the Hand and Foot3
Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma3
Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors3
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer3
Effect of Somatosensory Interaction Transcutaneous Electrical Acupoint Stimulation on Cancer-related Fatigue and Immunity3
Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma3
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer3
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer3
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer3
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation3
Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer3
Extraskeletal Myxoid Chondrosarcoma3
Preliminary Analysis of Cervical Cancer Immunotherapy3
Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant3
Sacituzumab Govitecan-hziy in Breast Cancer3
Stereotactic Body Radiotherapy for Prostate Cancer3
Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy3
Is There a Role for Perioperative Pelvic Radiotherapy in Surgically Resected Stage IV Rectal Cancer?3
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junc3
Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma3
Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease3
Diagnosis and Prognosis of Thyroid Cancer by Immune-related Genes3
Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer3
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer3
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases3
Cardiac Metastatic Tumors3
The Efficacy and Safety of Pazopanib Plus Chemotherapy in Treating Recurrent or Persistent Ovarian Cancer3
Cardiac Angiosarcomas3
Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation3
Pancreatic Cancer Clinical Treatment Trials Accrual3
Impact of Age on Overall Survival Among Children With Wilms Tumor3
Cardiovascular Diseases Following Breast Cancer3
Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases3
Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors3
0.051541090011597